Neuroinflammation & Alzheimer’s Disease | Prof. Michael Heneka on Immune Signaling and Neurodegeneration
Description
Why is Alzheimer’s disease so difficult to treat and how is the brain’s immune system involved?
Professor Michael Heneka, Director of the Luxembourg Centre for Systems Biomedicine, joins us to discuss key topics in #neuroinflammation and Alzheimer’s disease.
We explore how inflammation shapes the progression of #neurodegeneration, why detecting Alzheimer’s early remains a challenge, and the surprising biological world of tunneling nanotubes-tiny bridges that let cells exchange materials and signals.
Professor Heneka also breaks down emerging strategies in #prevention, #personalizedmedicine, #genetherapy, and anti-inflammatory approaches that could redefine the future of Alzheimer’s #treatment.
In this episode, you’ll learn:
• Why Alzheimer’s is so complex and why traditional #treatments struggle to stop its progression
• How #neuroinflammation drives the disease, reshaping the #brain long before symptoms appear
• How early #biomarkers can reveal Alzheimer’s up to 10 years in advance, improving detection and intervention
• The future of personalized Alzheimer’s #treatment, from #genetics to targeted #immunotherapies
• How tunneling nanotubes and #immune pathways may transform our understanding of #neurodegeneration
Subscribe to our YouTube channel and follow us for exciting neuroscience content.
🔗Link to our social media accounts: https://linktr.ee/neurosciencebeyond
#AlzheimersResearch #Neuroscience #BrainHealth #SystemsBiomedicine #NeurosciencePodcast
Supported by the International Max Planck Research School for Neurosciences in #Göttingen, the European Neuroscience Institute, Cluster of Excellence Multiscale Bioimaging, as well as SFB1286
Neuroscience and Beyond team:
Svilen Georgiev
Kristina Jevdokimenko
Ahsen Konaç Sayıcı
Mels Akhmetali
Laura van Agen
United States
